P0925 FECAL CALPROTECTIN: AN INDICATOR OF NEC IN VLBW INFANTS?
S. Josefsson, M. M. D. Domell f
Abstract
S. Josefsson, M. M. D. Domell f
Abstract
Introduction: Calprotectin is a calcium binding protein, abundant in neutrophils and stable in faeces. The aims of this study were to assess faecal calprotectin concentrations (f-calprotectin) in very low birth weight (VLBW, <1500 g) infants and to study possible differences in f-calprotectin between infants who develop severe abdominal disease and controls. Methods: Serial faecal samples were collected from 22 VLBW infants (4 cases of severe abdominal disease and 18 controls) and analysed for calprotectin. Results: Mean (SD) f-calprotectin in controls was 414 (417) mg/g faeces. In one case of necrotising enterocolitis (NEC) (stage III A) and one case of volvulus, f-calprotectin was increased to a maximum concentration of 22513 mg/g and 9228 mg/g, respectively. In two cases of isolated intestinal perforation, f-calprotectin never exceeded the range of controls. Conclusion: The observed f-calprotectin in VLBW infants is similar to that seen in full term infants. In one case of NEC, f-calprotectin was markedly increased and should our ongoing study support the findings of this interim analysis, f-calprotectin might be a useful marker of NEC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Introduction: Calprotectin is a calcium binding protein, abundant in neutrophils and stable in faeces. The aims of this study were to assess faecal calprotectin concentrations (f-calprotectin) in very low birth weight (VLBW, <1500 g) infants and to study possible differences in f-calprotectin between infants who develop severe abdominal disease and controls. Methods: Serial faecal samples were collected from 22 VLBW infants (4 cases of severe abdominal disease and 18 controls) and analysed for calprotectin. Results: Mean (SD) f-calprotectin in controls was 414 (417) mg/g faeces. In one case of necrotising enterocolitis (NEC) (stage III A) and one case of volvulus, f-calprotectin was increased to a maximum concentration of 22513 mg/g and 9228 mg/g, respectively. In two cases of isolated intestinal perforation, f-calprotectin never exceeded the range of controls. Conclusion: The observed f-calprotectin in VLBW infants is similar to that seen in full term infants. In one case of NEC, f-calprotectin was markedly increased and should our ongoing study support the findings of this interim analysis, f-calprotectin might be a useful marker of NEC.
Key concepts: Calprotectin, Medicine, Gastroenterology, Feces, Necrotizing enterocolitis, Internal medicine, Disease, Inflammatory bowel disease